[go: up one dir, main page]

WO2009020577A3 - Formulation innovante pour la délivrance orale d'insuline - Google Patents

Formulation innovante pour la délivrance orale d'insuline Download PDF

Info

Publication number
WO2009020577A3
WO2009020577A3 PCT/US2008/009365 US2008009365W WO2009020577A3 WO 2009020577 A3 WO2009020577 A3 WO 2009020577A3 US 2008009365 W US2008009365 W US 2008009365W WO 2009020577 A3 WO2009020577 A3 WO 2009020577A3
Authority
WO
WIPO (PCT)
Prior art keywords
insulin delivery
oral insulin
innovative formulation
formulation
innovative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/009365
Other languages
English (en)
Other versions
WO2009020577A2 (fr
Inventor
Allan E David
Arthur J Yang
Yoon Jeong Park
Li-Chien Chang
Victor C Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Science and Technology Network Inc
Original Assignee
Industrial Science and Technology Network Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Science and Technology Network Inc filed Critical Industrial Science and Technology Network Inc
Publication of WO2009020577A2 publication Critical patent/WO2009020577A2/fr
Publication of WO2009020577A3 publication Critical patent/WO2009020577A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne une formulation orale encapsulée mucoadhésive pour des hormones, telles que l'insuline, et des procédés pour utiliser ces formulations.
PCT/US2008/009365 2007-08-03 2008-08-04 Formulation innovante pour la délivrance orale d'insuline Ceased WO2009020577A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93529207P 2007-08-03 2007-08-03
US60/935,292 2007-08-03

Publications (2)

Publication Number Publication Date
WO2009020577A2 WO2009020577A2 (fr) 2009-02-12
WO2009020577A3 true WO2009020577A3 (fr) 2009-05-28

Family

ID=40341942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/009365 Ceased WO2009020577A2 (fr) 2007-08-03 2008-08-04 Formulation innovante pour la délivrance orale d'insuline

Country Status (1)

Country Link
WO (1) WO2009020577A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9896488B2 (en) 2013-06-18 2018-02-20 University Of Helsinki Protamine in treatment of neuronal injuries

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442043A (en) * 1992-11-27 1995-08-15 Takeda Chemical Industries, Ltd. Peptide conjugate
WO2004081188A2 (fr) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Peptides non toxiques de translocation dans la membrane

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442043A (en) * 1992-11-27 1995-08-15 Takeda Chemical Industries, Ltd. Peptide conjugate
WO2004081188A2 (fr) * 2003-03-10 2004-09-23 The Regents Of The University Of Michigan Peptides non toxiques de translocation dans la membrane

Also Published As

Publication number Publication date
WO2009020577A2 (fr) 2009-02-12

Similar Documents

Publication Publication Date Title
WO2007121318A3 (fr) Préparations destinées à l'administration d'insuline
WO2009086400A3 (fr) Formulation de vwf recombinant
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2010048275A3 (fr) Formulations de vwf recombinant lyophilisé
WO2009046444A3 (fr) Formulation pour administration intranasale de diazépame
WO2008057550A3 (fr) Stabilisation de vaccins par lyophilisation
WO2010021607A3 (fr) Préparation pharmaceutique
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
WO2008121767A3 (fr) Polypeptides cousus
WO2012076293A9 (fr) Préparations contenant des polysiloxanes dotés de groupes azotés
PL2081547T3 (pl) Postać galenowa do podawania składników czynnych poprzez śluzówkę
WO2009121039A3 (fr) Administration de compositions de benzodiazépine
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2007117556A3 (fr) Compositions pharmaceutiques et leurs utilisations
WO2009014855A3 (fr) Formulations d'encre et procédés de fabrication de formulations d'encre
WO2011017502A3 (fr) Formulations comprenant du linaclotide
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
PL2079446T3 (pl) Preparat paliperidonu o przedłużonym uwalnianiu
WO2006131591A3 (fr) Forme posologique destinee a etre administree par voie orale
WO2007130697A3 (fr) Anticorps anti-ephb4 et procedes qui les utilisent
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2004087100A3 (fr) Preparations a base de cladribine permettant une administration orale et transmucosale amelioree
WO2008046865A3 (fr) Système d'alimentation à long terme pour personnes agées
WO2009120380A3 (fr) Vecteurs de rhinovirus recombinants
WO2011002422A3 (fr) Formulation pharmaceutique améliorant la solubilité

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08780353

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08780353

Country of ref document: EP

Kind code of ref document: A2